Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.700
-0.030 (-1.73%)
At close: Oct 30, 2025, 4:00 PM EDT
1.740
+0.040 (2.35%)
After-hours: Oct 30, 2025, 7:56 PM EDT
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $197.59 million as of October 30, 2025. Its market cap has increased by 82.61% in one year.
Market Cap
197.59M
Enterprise Value
978.37K
1-Year Change
82.61%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $197.59M, a decrease of -51.12%. That is a compound annual growth rate of -6.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 201.10M | 26.48% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
| Nov 6, 2014 | 404.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 755.74B |
| Johnson & Johnson | 453.43B |
| AbbVie | 404.61B |
| UnitedHealth Group | 314.45B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 217.78B |